CRISPR Crunch

The new age of food? [Altucher Confidential] July 07, 2023 [WEBSITE]( | [UNSUBSCRIBE]( AI can change gene-editing. Gene-editing can change everything. [Hero_Image] CRISPR Crunch By: Ray Blanco Insider Reveals A Breakthrough New Way To Profit From AI Do not… I repeat… [Do NOT buy any AI stocks until you watch this short video in full.]( [Click here to learn more]( You’re about to discover a breakthrough new way to profit from the rise of AI that has never been revealed before. the types of companies we target with this strategy have shown top-performing gains like 1,167% in 11 days, 1,779% in 13 days and even 2,900% in just 3 days. Starting with $5,000, that’d be enough to walk away with profits like $63,350, $93,950 and $150,000 – all in a matter of days. But you must hurry… (As this is time sensitive). [Click here now for details on this new AI strategy.]( [Chris Campbell] CHRIS CAMPBELL Dear Reader, AI isn’t coming. It’s here. Yesterday, we saw how AI could help accelerate advances in biotech. For example, in the gritty world of drug discovery and development, AI rifles through mountains of biological and medical clues at a speed that would leave even Sherlock Holmes in awe. It picks out potential targets, predicts drug interactions, and essentially turns what used to be a slow and costly process into a high-speed chase. It doesn't stop there. AI even has the ability to simulate and analyze clinical trials, making them as efficient as a well-oiled machine. But that’s not even the most interesting part. AI can blitz through colossal genomic datasets, spotting patterns faster than you can say "double helix". With AI at the helm, diagnosis, prognosis, and treatments become more personalized than a monogrammed handkerchief. Furthermore… One of the most interesting, compelling (and controversial) things that AI could accelerate is gene-editing. Specifically, how gene-editing could affect our food supply. (Even more than it already has.). It’s a big issue. Today, we invited our colleague and resident tech maven Ray Blanco to talk specifics. Before we go there… Blast-Off! (Ray Was Right.) About a couple weeks ago, Ray announced his research on a tiny tech stock with huge potential. At the time, it was hovering around $1 per share. Today? It’s well over $2. And Ray believes this is just the beginning. In fact, this company’s success could become an issue of United States national security. Before the FOMO really kicks off… [Click here to check out Ray’s research… and see why this stock has such massive potential.]( And read on. Urgent From James Altucher! Hey, it’s James Altucher. I just announced a massive new change to Altucher’s Investment Network, and as one of my readers I wanted to make sure you know what’s going on. [Click here now to see my urgent announcement.]( Splicing A Salad: Gene-Editing Your Produce Ray Blanco [Ray Blanco] RAY BLANCO You’re probably at least somewhat familiar with the use of gene-editing in the development of drugs designed to treat diseases and genetic disorders. The most well known example is CRISPR, who has a treatment for sickle cell disease pending FDA approval by the end of this year. What you are probably unaware of is that CRISPR has been used to genetically modify a product that is already on the market. Lettuce. Conscious Greens, a type of mustard green from the North Carolina company Pairwise, has had the green’s signature pungency removed with CRISPR technology while retaining its high nutritional value. Conscious Greens is the first gene-edited food product to hit US markets. Pairwise hopes that Conscious Greens will be a healthier alternative to vitamin-light options like iceberg, romaine, or butter lettuce. While currently only available in select restaurants in only a few cities, Conscious Greens looks to expand soon to grocery stores in the Pacific Northwest. While making a certain kind of lettuce more appealing to a broader audience may sound like a small step forward that is a long way from solving world hunger, it serves as a very significant step in unlocking the potential of gene editing. The most obvious use-case of gene editing fruits and vegetables is to improve their yield. Larger crops, resistance to pests and disease, easier propagation, and faster harvests would all go a long way towards easing food shortages. As well as the cost of produce at your local grocery store. Beyond just creating more food, gene-editing could also “design” produce that would require less water. Creating an obvious benefit, particularly in farmlands vulnerable to droughts. Outside of Pairwise, gene-editing is currently in use for several other potential benefits. Such as increasing the number of kernels on an ear of corn and making cacao trees that are more resistant to disease. There have even been gene-edited cattle. CRISPR-editing has been used to make cows be able to endure hotter temperatures by giving them shorter coats. The Free Market Rules The Supermarket The USDA has already decided that gene-edited produce does not qualify as a genetically modified organism (GMO), which have long been considered to be an unhealthier version of the more “natural” product. Gene-editing only uses a plant’s own DNA to selectively emphasize positive traits while removing the negative. While GMOs introduce foreign genetic material, which could lead to unexpected allergic reactions and possibly increased resistance to antibiotics. But with regulators already clearing Conscious Greens and future gene-edited food, that doesn’t mean there’s a clear path ahead for these modified foods. Just because the USDA says you can consume something doesn’t mean that you should consume it. And even if you should, that doesn’t mean that you’ll want to. An animal’s liver is often the part of it that’s the most rich in nutrition, but it is also close to the least appealing to most consumers. According to a 2022 study, there is still a wide-spread reluctance to consume food that is considered to be “edited”, with 75% of people wanting any editing to be represented on the food’s label. Christopher Cummings, who conducted the survey, said… “People want to know how their food is made. They don’t want to feel duped…The direct-to-consumer benefit has not manifested in many technological food products in the past 30 years. If gene-edited foods are really going to take off, they need to provide a clear and direct benefit to people that helps them financially or nutritionally.” While the market has yet to decide on the fate of Pairwise’s Conscious Greens, there has been an example outside of the US of a commercially released CRISPR-edited food. In 2021, the Tokyo company Sanatech Seeds released a genetically edited tomato with increased amounts of y-aminobutyric acid, which they claim helped relieve stress and lower blood pressure. Japanese markets, with their famous inedible square watermelons, certainly don’t represent consumer sentiments in the United States or the rest of the world. So time will tell if CRISPR and other gene-editing technology can expand successfully beyond the medical field and into your kitchen. What do you think? Would you have an issue with eating genetically modified food? Are you more likely to eat edited fruits or vegetables than meat? Best, [Ray Blanco] Ray Blanco For Altucher Confidential Urgent Notice From Paradigm CIO Zach Scheidt! [James Altucher]( Urgent Notice From Paradigm CIO Zach Scheidt! Hi, Zach Scheidt here… I’m the Chief Income Officer at Paradigm Press. With inflation raging (and showing no signs of coming to an end any time soon), almost everyone in America is feeling the pain in a big way. Which is why, several months ago, I set out on a big mission… my goal was to create a [complete, step-by-step plan to surviving and beating inflation]( one that anyone could take advantage of. Today, after hundreds of hours of research, I’m revealing all of my findings. [Simply click here now to see how to survive America’s deadly inflation crisis](. [Paradigm]( ☰ ⊗ [ARCHIVE]( [ABOUT]( [Contact Us]( © 2023 Paradigm Press, LLC. 808 Saint Paul Street, Baltimore MD 21202. By submitting your email address, you consent to Paradigm Press, LLC. delivering daily email issues and advertisements. To end your Altucher Confidential e-mail subscription and associated external offers sent from Altucher Confidential, feel free to [click here.]( Please note: the mailbox associated with this email address is not monitored, so do not reply to this message. We welcome comments or suggestions at feedback@altucherconfidential.com. This address is for feedback only. For questions about your account or to speak with customer service, [contact us here]( or call (844)-731-0984. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of a printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Altucher Confidential is committed to protecting and respecting your privacy. We do not rent or share your email address. Please read our [Privacy Statement.]( If you are having trouble receiving your Altucher Confidential subscription, you can ensure its arrival in your mailbox by [whitelisting Altucher Confidential.](